DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Intron A (Interferon Alfa-2B) - Fatigue - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Fatigue (20)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Intron A (Interferon Alfa-2B) where reactions include fatigue. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Intron A side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Malaise, Fatigue, Renal Disorder, Blood Creatinine Increased, Loss of Consciousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A

Other drugs received by patient: Diovan; Amlodipine; Allopurinol; Lipitor; Renvela



Possible Intron A side effects in

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-07

Patient:

Reactions: Death, Poor Quality Sleep, Fatigue, Skin Lesion, Rash, Disease Progression, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Intron A

Other drugs received by patient: Methotrexate



Possible Intron A side effects in

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-01

Patient:

Reactions: Death, Poor Quality Sleep, Fatigue, Skin Lesion, Rash, Decreased Appetite, Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Intron A

Other drugs received by patient: Methotrexate



Possible Intron A side effects in male

Reported by a physician from United States on 2012-07-31

Patient: male, weighing 112.0 kg (246.4 pounds)

Reactions: Weight Decreased, Abdominal Pain, Nausea, Chills, Dysstasia, Fatigue, Diarrhoea, Dehydration, Dizziness, Fluid Intake Reduced

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-30

Patient: female, weighing 75.0 kg (165.0 pounds)

Reactions: Fatigue, Nausea, Abnormal Behaviour, Cognitive Disorder, Memory Impairment, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-07-24

Patient:

Reactions: Poor Quality Sleep, Death, Fatigue, Skin Lesion, Rash, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Intron A

Other drugs received by patient: Methotrexate



Possible Intron A side effects in male

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-06-22

Patient: male

Reactions: Nausea, Chills, Pain, Radiation Skin Injury, Pyrexia, Treatment Noncompliance, Rash Pruritic, Fatigue, Lymph Node Pain, Liver Function Test Abnormal, Swelling, Asthenia, Lymphoedema, Post Procedural Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A (Interferon Alfa-2B)
    Dosage: 40 miu;;iv, 30 miu,,iv,
    Indication: Malignant Melanoma
    Start date: 2011-11-17
    End date: 2011-12-02

Intron A (Interferon Alfa-2B)
    Dosage: 40 miu;;iv, 30 miu,,iv,
    Indication: Malignant Melanoma
    Start date: 2011-11-07

Intron A
    Dosage: 20 miu; unk;, 15 miu;tiw;, 10 miu;tiw, 10 miu,tiw;
    Indication: Malignant Melanoma
    Start date: 2012-01-13
    End date: 2012-01-25

Intron A
    Dosage: 20 miu; unk;, 15 miu;tiw;, 10 miu;tiw, 10 miu,tiw;
    Indication: Malignant Melanoma
    Start date: 2012-02-13

Intron A
    Dosage: 20 miu; unk;, 15 miu;tiw;, 10 miu;tiw, 10 miu,tiw;
    Indication: Malignant Melanoma
    Start date: 2011-12-05

Other drugs received by patient: Levothyroxine Sodium



Possible Intron A side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-05-23

Patient: female

Reactions: Renal Function Test Abnormal, Food Poisoning, Pain, Chills, Blood Count Abnormal, Headache, Pyrexia, Lower Respiratory Tract Infection, Fatigue, Liver Function Test Abnormal, Feeling of Body Temperature Change, Blood Pressure Abnormal, Blood Creatinine Increased, Lethargy, Blood Test Abnormal, Salmonella Sepsis, Dyspnoea, Cardiac Flutter, Nausea, Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-06
    End date: 2011-12-01

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
    Indication: Malignant Melanoma
    Start date: 2012-01-16

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
    Indication: Malignant Melanoma
    Start date: 2011-08-29

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-03

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-16

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv 22.4 miu;tiw 22.5 miut;tiw
    Indication: Malignant Melanoma
    Start date: 2012-05-07

Other drugs received by patient: Micardis; Amlodipine Besylate; Amlodipine Besylate; Atiacid; Zofran; Acetaminophen



Possible Intron A side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-27

Patient: female

Reactions: Weight Decreased, Buccal Mucosal Roughening, Skin Exfoliation, Blood Count Abnormal, Pallor, Rash Pruritic, Loss of Consciousness, Fatigue, Tongue Disorder, Skin Discolouration, Dizziness, Musculoskeletal Stiffness, Skin Haemorrhage, Depression, Decreased Appetite, Psychomotor Hyperactivity, Amnesia, Syncope, Throat Irritation, Dysphonia, Alopecia, Mental Disorder, Memory Impairment, Asthenia, Scar

Drug(s) suspected as cause:
Intron A
    Indication: Hepatitis C
    Start date: 2000-01-01
    End date: 2000-06-01

Ribavirin
    Indication: Hepatitis C
    Start date: 2011-10-13
    End date: 2012-04-05

PEG-Intron
    Indication: Hepatitis C
    Start date: 2001-01-01
    End date: 2001-03-01

PEG-Intron
    Indication: Hepatitis C
    Start date: 2011-10-13
    End date: 2012-04-05

Telaprevir
    Indication: Hepatitis C
    Start date: 2011-10-13
    End date: 2012-04-05



Possible Intron A side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-12

Patient: male

Reactions: Dyspnoea, Nausea, Flatulence, Headache, Abdominal Pain Upper, Dysgeusia, Fatigue, Dyspepsia, Insomnia, Thyroid Disorder, Abdominal Distension, Hypothyroidism

Drug(s) suspected as cause:
Intron A
    Indication: Hepatitis C
    Start date: 1998-01-02
    End date: 1998-11-27

PEG-Intron
    Indication: Hepatitis C
    Start date: 2012-01-13

PEG-Intron
    Indication: Hepatitis C
    Start date: 2001-04-06
    End date: 2003-04-04

Victrelis
    Indication: Hepatitis C
    Start date: 2012-02-11

Pegasys
    Indication: Hepatitis C
    Start date: 2009-01-02
    End date: 2009-11-27

Ribavirin
    Start date: 2009-01-02
    End date: 2009-11-27

Ribavirin
    Start date: 2001-04-06
    End date: 2003-04-04

Ribavirin
    Start date: 2012-01-12



Possible Intron A side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-04-12

Patient: female

Reactions: Salmonella Sepsis, Dyspnoea, Cardiac Flutter, Renal Function Test Abnormal, Nausea, Chills, Food Poisoning, Headache, Rash, Lower Respiratory Tract Infection, Laboratory Test Abnormal, Fatigue, Liver Function Test Abnormal, White Blood Cell Count Increased, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A
    Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-03

Intron A
    Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-16

Intron A
    Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
    Indication: Malignant Melanoma
    Start date: 2012-01-16

Intron A
    Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
    Indication: Malignant Melanoma
    Start date: 2011-08-29

Intron A
    Dosage: 40 miu; iv, 30 miu; iv, 22.6 miu; tiw; iv, 22.6 miu; tiw, 22.6 miu; tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-06
    End date: 2011-12-01

Other drugs received by patient: Micardis; Antiacid; Zofran; Acetaminophen



Possible Intron A side effects in male

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-03-02

Patient: male

Reactions: Nausea, Pain, Chills, Radiation Skin Injury, Pyrexia, Thermal Burn, Rash Pruritic, Fatigue, Liver Function Test Abnormal, Asthenia, Post Procedural Infection, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A
    Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2012-02-13

Intron A
    Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-11-07

Intron A
    Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2012-01-13
    End date: 2012-01-25

Intron A
    Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-11-17
    End date: 2011-12-02

Intron A
    Dosage: 40 miu;iv, 30 miu;iv, 20 miu;unk, 15 miu;tiw, 10 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-12-05

Other drugs received by patient: Levothyroxine Sodium



Possible Intron A side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-02-07

Patient: female

Reactions: Dyspnoea, Cardiac Flutter, Nausea, Body Temperature Increased, Chills, Headache, Rash, Lower Respiratory Tract Infection, Fatigue, Liver Function Test Abnormal, Lethargy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A
    Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-16

Intron A
    Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-06
    End date: 2011-12-01

Intron A
    Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2012-01-16

Intron A
    Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-10-03

Intron A
    Dosage: 40 miu; ;iv 30 miu; ;iv 22.6 miu; ;tiw;iv; 22.6 miu;tiw ; 22.6 miu;tiw
    Indication: Malignant Melanoma
    Start date: 2011-08-29

Other drugs received by patient: Micardis; Zofran; Antiacid; Acetaminophen



Possible Intron A side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2011-12-19

Patient: female

Reactions: Dyspnoea, Cardiac Flutter, Nausea, Chills, Headache, Rash, Fatigue, Liver Function Test Abnormal, Lethargy

Drug(s) suspected as cause:
Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
    Indication: Malignant Melanoma
    Start date: 2011-10-16

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
    Indication: Malignant Melanoma
    Start date: 2011-08-29

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
    Indication: Malignant Melanoma
    Start date: 2011-10-06

Intron A
    Dosage: 40 miu;iv 30 miu;iv 22.6 miu;tiw;iv
    Indication: Malignant Melanoma
    Start date: 2011-10-03

Other drugs received by patient: Micardis; Zofran; Antacid; Acetaminophen



Possible Intron A side effects in female

Reported by a physician from United States on 2011-11-28

Patient: female, weighing 75.0 kg (165.0 pounds)

Reactions: Refusal of Treatment by Patient, Fatigue, Nausea, Abnormal Behaviour, Cognitive Disorder, Memory Impairment, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in female

Reported by a physician from United States on 2011-11-14

Patient: female, weighing 57.7 kg (126.9 pounds)

Reactions: Fatigue, Nausea, Urinary Tract Infection, Neutropenia, Asthenia

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in female

Reported by a physician from United States on 2011-11-08

Patient: female, weighing 70.0 kg (154.0 pounds)

Reactions: Small Intestinal Obstruction, Fatigue, Headache

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sandostatin
    Dosage: 20 mg
    End date: 2011-10-26

Intron A
    Dosage: 15 million iu
    End date: 2011-10-31



Possible Intron A side effects in female

Reported by a physician from United States on 2011-11-07

Patient: female, weighing 57.7 kg (126.9 pounds)

Reactions: Fatigue, Nausea, Urinary Tract Infection, Neutropenia, Asthenia

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2011-10-31

Patient: female

Reactions: Fatigue, Cardiac Flutter, Body Temperature Increased, Nausea, Chills, Liver Function Test Abnormal, Headache

Drug(s) suspected as cause:
Intron A
    Dosage: unk;unk
    Indication: Malignant Melanoma
    Start date: 2011-10-16

Intron A
    Dosage: 40 miu;unk;iv, 30 miu;unk;iv, 22.6 miu;tiw;iv
    Indication: Malignant Melanoma
    Start date: 2011-10-03

Intron A
    Dosage: 40 miu;unk;iv, 30 miu;unk;iv, 22.6 miu;tiw;iv
    Indication: Malignant Melanoma
    Start date: 2011-08-29

Other drugs received by patient: Zofran; Acetaminophen; Micardis; Antacid



Possible Intron A side effects in male

Reported by a physician from United States on 2011-10-25

Patient: male, weighing 88.0 kg (193.6 pounds)

Reactions: Fatigue

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012